Gold Strike reported 100,487,689 common shares represented on Oct. 21; all matters in its Sept. 15 materials were approved by ...

A foundry customer validated the system across more than 50 process layers; ACM reports particle counts of 15 or fewer at 15 nm and above.

Exclusivity began Feb. 3, 2025, ONAPGO’s FDA approval date. ONAPGO treats motor fluctuations in adults with advanced Parkinson’s disease.

The $1.35 dividend is payable Nov. 20 to shareholders of record on Nov. 6; the company says it has paid dividends since its 1982 formation.

DyFlex works in mining, energy, manufacturing and the public sector. The proposed deal is expected to close in Q1 2027, subject to approvals.

Its Class A registration with the SEC is expected to end 90 days after the Form 25 filing; shares are expected to remain quoted on OTC Pink following delisting.

A webcast and supporting materials will be available on Amcor’s investor website, with a replay after the call; the reporting period ended Sept. 30.

Proceeds will go toward repaying or redeeming 5.5% notes due 2027; settlement is expected Oct. 28, subject to customary closing conditions.

Nine banking center consolidations and 66 position eliminations are expected to lower expenses in Q4, with an expected annual pre-tax income increase of over $2 million.

FDA approved its citrate and calcium solutions for adults and children weighing at least 40 kg; controlled U.S. rollout precedes full availability.

Since joining CannaFirst Financial in March 2025 as Director of National Sales, Perry will lead its strategic direction and business development.

AEVEX delivered 325 GARC units in 2025; its mine-countermeasure packages are conducting missions in the Strait of Hormuz under a contract extended through June 2027.